The top 20 pharmaceutical companies have implemented a raft of new initiatives in the last two years. Yet in two important areas, progress remains static.

› Go to Key Findings

The industry pipeline is concentrated on five diseases. Five companies are developing more than half the products for developing countries.

› Go to Key Findings

Half of the companies in the Index are developing medicines tailored for children, with 7% of the overall research pipeline being devoted to “child-size” medicine.

› Go to Key Findings

More companies are tailoring their prices to different segments of national populations.

› Go to Key Findings

Home

New Article

Download the report

Download the report

2014 Index Ranking

Latest News

Jayasree K. Iyer to chair panel on barriers to NCDs in sub-Saharan Africa

24 August 2016 |
On 26 August in Nairobi, Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation, will chair a panel at TICAD VI of experts, discussing the challenge of treating non-communicable diseases in sub-Saharan Africa.› Read more

Shifting mindsets to improve access to medicine

2 August 2016 |
What levers need to be pulled to improve access to medicine worldwide? Jayasree K. Iyer, Executive Director, shares ideas that would lead to more people accessing the medicine they need. › Read more

2016 Access to Medicine Index: out in November

8 July 2016 |
The Access to Medicine Foundation is preparing a new iteration of its leading sustainability Index of pharmaceutical companies – the next Access to Medicine Index will be published in November 2016.› Read more

Now online: Going beyond CSR to reach ‘the two billion’ by Jayasree K. Iyer for PharmaPhorum

1 July 2016 |
Writing on PharmaPhorum, Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation, shows how pharma companies are taking access to medicine beyond CSR, and putting it at the core of their businesses.› Read more

Access to Vaccines Index: the data is in, analysis can begin

10 June 2016 |

The Access to Vaccines Index will analyse how vaccine companies are improving access to high-priority vaccines for communities in need.

› Read more

What Leaders Say

Dr. Margaret Chan
Director-General, World Health Organization
"The Access to Medicine Index is a very important project. What gets measured, gets done."
Bill Gates
Chairman of Microsoft Corporation, Co-Chair and Trustee of the Bill & Melinda Gates Foundation
"When I talk to executives from pharmaceutical companies they tell me that they want to do more for neglected diseases, but they at least need to get credit for it. The Access to Medicine Index does exactly that."
Justine Greening
Justine Greening
The Rt Hon Justine Greening MP, Secretary of State for International Development, UK
"This year’s index shows that the pharmaceutical industry has made progress in improving access to vital medicines for the globe’s poorest people, helping to tackle some of the world’s worst diseases. The deadly Ebola outbreak reminds us that there is still much to be done to stop the spread of diseases in developing countries."
Lilianne Ploumen
Minister for Foreign Trade and Development Cooperation, the Netherlands
“The Access to Medicine Index mobilizes the strength of the private sector, impacting the lives of millions of the most vulnerable people on earth. It showcases the synergy of aid, trade and investment.”
Knut Kjaer
Former CEO of RiskMetrics Group, Former CEO of Norges Bank Investment Management (NBIM) (1997-2007)
"Companies are beginning to understand that the value of corporate social responsibility programmes is not only the opportunity to do the right thing but that it's good for business as well. The Access to Medicine Index provides companies with a chance to improve performance and explore new business models while helping societies in need."

In the Media

ET Healthworld interviews Jayasree K. Iyer on Access to Vaccines Index

9 August 2016 |

Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation, talks about the importance of vaccines and the role of vaccine manufacturers in ensuring they reach the people who need them.

› Read more

Article in Devex on innovations in access to medicines underway quotes Jayasree K. Iyer

1 August 2016 |

As part of the 'Access to Medicine' campaign, Andrew Green quotes Jayasree K. Iyer, Executive Director, on innovations needed to spur improved access to medicines for people in the developing world.

› Read more

'Bringing medicines to the world' on Devex, quoting Jayasree K. Iyer on pharma company practice

20 July 2016 |

As part of the 'Access to Medicine' campaign, Flavie Halais quotes Jayasree K. Iyer, Executive Director, on progress some pharma companies are making in pricing and licensing certain medicines for the poor.

› Read more

Pharmaphorum publishes Jayasree K. Iyer's viewpoint on 'Going beyond CSR..'

1 July 2016 |

Jayasree K. Iyer shares her viewpoint on how pharma companies are taking access to medicine beyond CSR, and putting it at the core of their businesses on Deepdive by Pharaphorum.  

› Read more

Jayasree K. Iyer featured in The Medicine Maker Power List 2016

29 April 2016 |

Jayasree K. Iyer, Executive Director at the Access to Medicine Foundation was featured as one among the top 100 influential people in the world of drug development and manufacture, as published by The Medicine Maker in their Power List 2016

› Read more